Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04857255 · ClinicalTrials.gov registry record · NA
Technology-assisted Language Intervention (TALI)
A NA study of Language Development and Hearing Loss, Bilateral, sponsored by Children's Hospital Medical Center, Cincinnati.
- Active
- Registry status
- NA
- Development phase
- 114
- Enrollment target
- 2
- Study locations
NCT04857255: Active NA study of Language Development and Hearing Loss, Bilateral, sponsored by Children's Hospital Medical Center, Cincinnati.
NCT04857255 is a NA study of Language Development and Hearing Loss, Bilateral that is active but no longer recruiting, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 114 participants, above the 99-participant average among 13 other Language Development trials with a reported enrollment target (15% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04857255, a NA study of Language Development and Hearing Loss, Bilateral, is active but no longer recruiting, sponsored by Children's Hospital Medical Center, Cincinnati.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 114 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study is testing the effectiveness of augmentative and alternative communication technology among deaf or hard of hearing children for improving language development. Children will be randomized to receive either the technology intervention or treatment as usual
Primary Outcome
Measurement of syntax
Conditions Studied
Interventions
- BEHAVIORAL Treatment as usual
- BEHAVIORAL Technology assisted language intervention
Study Locations (2)
Colorado
- Children's Hospital of Colorado - Aurora
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 2020-10-15 |
| Est. Completion | 2026-03-31 |
| Phase | NA |
What the registry record for NCT04857255 still lists
NCT04857255 is an interventional study that assigns participants to a tested intervention. The registered 114 participants enrollment target is mid-sized for trials with a published cap, above the 99-participant average among 13 other Language Development trials with a reported enrollment target (15% higher).
The record links to 2 conditions, with Language Development appearing as the primary indexed condition, and to 2 interventions - of which Treatment as usual is the first listed.
NCT04857255 reports a single indexed study location in Colorado, Ohio.
Frequently Asked Questions
What is clinical trial NCT04857255 about?
NCT04857255 is a clinical study titled "Technology-assisted Language Intervention (TALI)". This study is testing the effectiveness of augmentative and alternative communication technology among deaf or hard of hearing children for improving language development. Children will be randomized to receive either the technology intervention or treatment as usual
What is the current status of trial NCT04857255?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 114 participants. The study started on 2020-10-15. Estimated completion is 2026-03-31.
What conditions does trial NCT04857255 study?
This clinical trial studies the following conditions: Language Development, Hearing Loss, Bilateral.
What interventions are being tested in trial NCT04857255?
The interventions under investigation include: Treatment as usual (BEHAVIORAL), Technology assisted language intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04857255?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04857255 being conducted?
This trial has 2 study locations across Colorado, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Language Development
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04857255's enrollment target sits among peer trials
114 5th of 13 higher than 9 of 13 other Language Development trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Language Development trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Impact of Music Medicine on Preterm Brain Development and Behavior
RECRUITING · NA
-
Retrieval-based Word Learning in Developmental Language Disorder: Adaptive Retrieval Schedule
RECRUITING · NA
-
Talk With Me Baby to Enhance the Early Home Language Environment
RECRUITING · NA
-
Combined Oral Motor Stimulation and Language on Preterm Infant Feeding
RECRUITING · NA
-
Retrieval-Based Word Learning in Developmental Language Disorder During Book Reading II
RECRUITING · NA
-
Improving Outcomes Using Technology for Children Who Are DHH
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04522791 · 114 participants · Phase 2
Breathing, Relaxation, Attention Training, & Health in Older Adults (BREATHE)
- NCT04875052 · 114 participants · NA
Vibration and Post-traumatic Osteoarthritis Risk Following ACL Injury
- NCT05100342 · 114 participants
Prospective Validation of a Points Score System Predicting 30-day Survival
- NCT05224089 · 114 participants · Phase 4
Bilateral TAP and RS Blocks Using Liposomal Bupivacaine/Bupivacaine vs. Regular Bupivacaine in Laparoscopic Colectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI